- Home
- CMPS vs AEHR Comparison
CMPS vs AEHR Comparison
Compare CMPS & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- AEHR
- Stock Information
- Founded
- CMPS 2020
- AEHR 1977
- Country
- CMPS United Kingdom
- AEHR United States
- Employees
- CMPS N/A
- AEHR N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- AEHR Electrical Products
- Sector
- CMPS Health Care
- AEHR Industrials
- Exchange
- CMPS Nasdaq
- AEHR Nasdaq
- Market Cap
- CMPS 246.5M
- AEHR 214.5M
- IPO Year
- CMPS 2020
- AEHR 1997
- Fundamental
- Price
- CMPS $3.51
- AEHR $8.15
- Analyst Decision
- CMPS Strong Buy
- AEHR
- Analyst Count
- CMPS 6
- AEHR 0
- Target Price
- CMPS $20.20
- AEHR N/A
- AVG Volume (30 Days)
- CMPS 836.8K
- AEHR 940.5K
- Earning Date
- CMPS 05-07-2025
- AEHR 04-08-2025
- Dividend Yield
- CMPS N/A
- AEHR N/A
- EPS Growth
- CMPS N/A
- AEHR 50.16
- EPS
- CMPS N/A
- AEHR 0.78
- Revenue
- CMPS N/A
- AEHR $61,479,000.00
- Revenue This Year
- CMPS N/A
- AEHR N/A
- Revenue Next Year
- CMPS N/A
- AEHR $22.53
- P/E Ratio
- CMPS N/A
- AEHR $10.07
- Revenue Growth
- CMPS N/A
- AEHR N/A
- 52 Week Low
- CMPS $2.49
- AEHR $6.27
- 52 Week High
- CMPS $9.63
- AEHR $21.44
- Technical
- Relative Strength Index (RSI)
- CMPS 60.07
- AEHR 48.26
- Support Level
- CMPS $2.94
- AEHR $7.71
- Resistance Level
- CMPS $3.11
- AEHR $8.84
- Average True Range (ATR)
- CMPS 0.22
- AEHR 0.73
- MACD
- CMPS 0.11
- AEHR 0.13
- Stochastic Oscillator
- CMPS 93.57
- AEHR 75.97
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About AEHR Aehr Test Systems
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.